Trial intelligence / Profile preview

Liposomal Bupivacaine vs Ropivacaine Cocktail vs cFNB for Pain After TKA

NCT02369523Phase 1Terminated

Sponsor
University of Utah
Start
Sep 2014
Primary completion
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of bupivacaine in postoperative pain (3 arms), sponsored by University of Utah. Primary endpoint: Time to Discharge Readiness. Started Sep 2014; status: terminated.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02369523.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02369523.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call